about
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble DrugsA look at emerging delivery systems for topical drug productsToxicology and drug delivery by cucurbit[n]uril type molecular containersModified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterizationEnhancing anti-tumor efficacy of Doxorubicin by non-covalent conjugation to gold nanoparticles - in vitro studies on feline fibrosarcoma cell linesThe Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic CancersReducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel NanoconjugatesPharmacokinetics, efficacy, and safety evaluation of docetaxel/hydroxypropyl-sulfobutyl-β-cyclodextrin inclusion complexDrug Release from ß-Cyclodextrin Complexes and Drug Transfer into Model Membranes Studied by Affinity Capillary Electrophoresis.Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia.Innovative oral spray-dried Idebenone systems to improve patient compliance.Regioselective self-acylating cyclodextrins in organic solvent.Synthesis, Characterization, and Retinol Stabilization of Fatty Amide-β-cyclodextrin Conjugates.Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo.Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected]Gallic acid/hydroxypropyl-β-cyclodextrin complex: Improving solubility for application on in vitro/ in vivo Candida albicans biofilms.Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gelExploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.Ocular onchocerciasis: current management and future prospectsCyclodextrins.Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric useBridging of a substrate between cyclodextrin and an enzyme's active site pocket triggers a unique mode of inhibitionCavamax W7 composite psoralen ethosomal gel versus cavamax W7 psoralen solid complex gel for topical delivery: A comparative evaluationSolid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylateEnhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital useCytotoxicity of purified listeriolysin O on mouse and human leukocytes and leukaemia cellsAdvanced technologies for oral controlled release: cyclodextrins for oral controlled release.Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B.A promising antitumor activity of evodiamine incorporated in hydroxypropyl-β-cyclodextrin: pro-apoptotic activity in human hepatoma HepG2 cells.Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.3D visualization of additive occlusion and tunable full-spectrum fluorescence in calcite.A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs.The Effect of Lycopene Preexposure on UV-B-Irradiated Human Keratinocytes.Nonclinical vehicle use in studies by multiple routes in multiple species.
P2860
Q26779030-A95137BD-AA10-4109-BF8E-8250469F36D4Q28260432-62EC77F6-D125-4A3D-85C5-EEE94554B3EAQ28473864-50BCCA87-8BDB-4D63-BE98-EC15E6CB40D1Q28539812-56384715-7730-4DBF-9206-7ACD3792171FQ28546881-A6CF6B60-883E-469B-84C3-E5F0AEBC80CAQ28551531-19B6B35E-FCA1-45BA-9E43-2A3A9825E68CQ28553214-AEAA17DB-A689-432C-B176-F58B90A164C1Q28742710-5E9E92C9-ED6A-410E-90C4-D4CF322840EAQ30315728-028C62B2-F329-4C6D-8173-D52A1F82F479Q30445260-A00A73B9-34D1-4F60-A479-3023BEDEB047Q30829560-CE995456-00E5-4496-B99E-7612B63E3BC8Q31021104-42C420C4-9756-4E98-B8DD-83C08919A75DQ31064261-17F2F60D-BF43-40F3-9F75-764FD055BB55Q31117339-D3B3C8F8-67DA-4C3F-9791-9355109F858DQ33518672-B8BB3252-FC5B-4942-829F-29F55DC72E74Q33844624-EDD7B24F-333A-4A2F-AAF1-A451C83A5A81Q33873730-A402621A-6E5D-4A67-AAD5-C27BDDE7B037Q33898241-2F59D0A5-48BD-4AF3-8857-47D80FA8830AQ33986035-FBC9708A-82DF-418C-BC1D-AA201DC66178Q34142658-E16352E1-B31D-451A-A78A-53B6C0D6E43EQ34284551-154D30E9-3761-4C8A-8BD0-6B97731EEAEBQ34613962-7DE733C4-4256-4F9A-B19B-628FF5C08418Q34633609-908E96EA-CC93-46E6-B453-5CF049A77A6DQ34761190-166F5EE1-6125-4705-B44B-66645B25C79BQ34769107-F0038CB4-555E-42B4-B3E5-68FD8414AF8EQ34797798-A001ADDF-72B2-41E9-9F90-8E8CBC551005Q35071238-ED85903D-4EC3-4F7E-8E3D-557239A9BA84Q35088391-967788DD-8CB8-48C3-B010-9AF91E6FCFD9Q35100405-50F68A94-5BDC-4EC3-ADB0-9839A3AC1163Q35110669-556B8DE1-3EE1-470E-879D-D587862CD789Q35143230-31C45956-B1D7-4F82-8DF6-4A8F4BFFCBBCQ35227459-79B26E86-3AEB-4069-BC25-4049F58A706EQ35577222-226D2367-AC96-46C8-B793-A778391CB370Q35666408-55DED31B-BBE4-422E-A742-811E11FF1B02Q36085681-F8BF35A8-E0EF-4500-B7AA-CD9E9428617AQ36161028-E5164E07-194B-43E1-AD10-71C57AFB299CQ36195833-B0F5CD63-D036-4798-8C29-763052F9A74AQ36259762-7F188C83-8EEF-4C95-96F6-DD5E06B4E045Q36333137-CC866EA6-4F4E-4721-828A-B68FE85CEA99Q36667231-861EA5D6-A5AD-4B5B-8AF2-BBA5A95B0E95
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cyclodextrins in drug delivery: an updated review
@ast
Cyclodextrins in drug delivery: an updated review
@en
Cyclodextrins in drug delivery: an updated review
@nl
type
label
Cyclodextrins in drug delivery: an updated review
@ast
Cyclodextrins in drug delivery: an updated review
@en
Cyclodextrins in drug delivery: an updated review
@nl
prefLabel
Cyclodextrins in drug delivery: an updated review
@ast
Cyclodextrins in drug delivery: an updated review
@en
Cyclodextrins in drug delivery: an updated review
@nl
P2093
P2860
P356
P1433
P1476
Cyclodextrins in drug delivery: an updated review
@en
P2093
Alka Ahuja
Rajeswari Challa
P2860
P2888
P304
P356
10.1208/PT060243
P407
P50
P577
2005-10-14T00:00:00Z
P5875
P6179
1044260812